Global Market Study on Ophthalmic Devices: Asia to Witness Highest Growth by 2020


  • Published On : Sep-2014 |
  • Pages : 120 Pages |
  • Format :

Ophthalmology is the branch of medical science that deals with the management and study of anatomy, physiology, and diseases related to the human eye. Globally, the incidence of eye disorders and vision loss are becoming major public health issues. Some of the major eye diseases include age-related macular degeneration, glaucoma, cataract, bulging eyes, diabetic macular edema, ocular hypertension, retinal detachment, uveitis, and refractive errors. Ophthalmic devices are medical devices used to identify ocular defects or deficiencies and treat eye disorders. Ophthalmic technology is constantly developing for the better treatment for eye diseases and restoration of vision, resulting in more people opting for ophthalmic surgeries to rectify eye-related disorders.

Increasing prevalence of eye-related disorders, such as macular degeneration and diabetic retinopathy; globally aging population and rising government initiatives towards healthcare infrastructure in developing countries are the key driving factors for the global ophthalmic devices market. In addition, increasing prevalence of lifestyle-associated diseases, such as diabetes and high blood pressure are also fueling the growth of the market. In future, increasing use of intraocular lenses and phacoemulsification devices in emerging countries would provide opportunities to new entrants, which would further propel the growth of the global ophthalmic devices market.

On the other hand, general lack of awareness among people about eye disorders and poor primary healthcare infrastructure coupled with lack of healthcare insurance are major factors restraining the global ophthalmic devices market. In addition, rising healthcare cost in developing countries, such as India and China, is hampering affordability of healthcare facilities among the aging population. Majority of the population does not have access to primary healthcare services, attributable to poverty and absence of health insurance.

North America dominates the global market for ophthalmic devices due to large number of age-related eye diseases, such as glaucoma, cataract, diabetic retinopathy, and age-related macular degeneration, are the leading causes of visual impairment and blindness. Asia is to show high growth rates in the next five years in the global ophthalmic devices market. China and India are expected to be the fastest growing ophthalmic devices markets in Asia-Pacific region. Some of the key driving forces for ophthalmic devices market in emerging countries are large pool of patients and rising government initiatives and support. 

This report provides in-depth analysis and estimation of the global ophthalmic devices market for the period 2014 to 2020, considering 2013 as the base year for calculation. In addition, data pertaining to current market dynamics, including market drivers, restraints, trends, and recent developments, has been provided in the report. The global ophthalmic devices market is categorized on the basis of type and geography. Based on type, the ophthalmic devices market comprises vision care devices, surgery devices, and diagnostic devices. Vision care devices comprise spectacle lenses and contact lenses. Diagnostic devices comprise optical coherence tomography scanner, slit lamp, fundus camera, visual field analyser, tonometer, retinoscope ophthalmoscope, and others. On the basis of geography, the report identifies and analyses market size and forecast of North America, Europe, Asia, and Rest of the World (RoW).

Globally, the ophthalmic devices market is witnessing significant growth due to increasing prevalence of eye disorders, such as diabetic retinopathy and macular degeneration. In addition, growing global aging population, increasing government initiatives towards healthcare infrastructure in developing countries, and increasing incidence of lifestyle-associated diseases are also driving the growth of the market. However, lack of awareness among people about eye disorders, poor primary healthcare infrastructure, and lack of insurance in developing countries hamper growth of the global ophthalmic devices market. In addition, eye diseases in children are also increasing due to the general lack of awareness.

The global ophthalmic devices market is anticipated to grow from an estimated USD 29,171.5 million in 2014 to USD 42,685.1 million in 2020 at a CAGR of 6.5% during the forecast period.

North America is the largest market for global ophthalmic devices. Vision care devices are the most used type of ophthalmic devices, spectacles lenses are the most used type of vision care ophthalmic device and cataract surgery devices are the most popular type of ophthalmic surgical device. In terms of growth, Asia is the fastest growing region; ophthalmic surgical devices make for the fastest growing type of devices, while contact lenses make for the fastest growing type of vision care ophthalmic devices.

The North American market is anticipated to grow from an estimated USD 11,450.6 million in 2014 to USD 16,242.8 million in 2020, growing at a CAGR of 6% during the forecast period.

Some of the major players in the global ophthalmic devices market:

  • Johnson & Johnson.
  • Essilor International.
  • Bausch & Lomb Incorporated.
  • Novartis AG.
  • HOYA CORPORATION.
  • Abbott Laboratories, Inc.
  • Other.

These key market players of ophthalmic devices market have been profiled on the basis of attributes such as company overview, recent developments, growth strategies, sustainability, and financial overview.

Chapter 1 Preface

1.1 Report description

1.2 Research methodology

1.3 Assumptions

Chapter 2 Market synopsis

Chapter 3 Porter’s five forces analysis

3.1 Bargaining power of suppliers

3.2 Bargaining power of buyers

3.3 Threat of new entrants

3.4 Threat of substitutes 

3.5 Intensity of rivalry 

Chapter 4 Industry overview 

4.1 Market definition 

4.2 Market drivers 

      4.2.1 Globally aging population 

      4.2.2 Increasing prevalence of eye disorder 

      4.2.3 Increasing prevalence of lifestyle-associated diseases 

      4.2.4 Rising government initiatives towards healthcare infrastructure in developing countries 

      4.2.5 Technological advancements in ophthalmic devices 

4.3 Impact analysis of market drivers 

4.4 Market restraints 

      4.4.1 Lack of awareness among people about eye disorders 

      4.4.2 Poor primary healthcare infrastructure and lack of healthcare insurance 

4.5 Impact analysis of market restraints 

4.6 Opportunities 

      4.6.1 Increased use of intraocular lenses and phacoemulsification devices in emerging countries 

4.7 Market trends 

      4.7.1 Increasing use of electronic medical record in ophthalmology 

      4.7.2 Usage of femtosecond lasers in cataract surgery 

      4.7.3 Minimally invasive surgery for ophthalmic treatment 

      4.7.4 Rising number of product innovation 

Chapter 5 Global market size and forecast 

Chapter 6 Market size and forecast by type

6.1 Vision care devices 

6.2 Surgery devices 

6.3 Diagnostic devices

Chapter 7 Market size and forecast by vision care devices

7.1 Contact lenses 

7.2 Spectacle lenses 

Chapter 8 Market size and forecast by surgery devices 

8.1 Cataract surgery devices 

8.2 Glaucoma surgery devices 

8.3 Refractive error surgery devices 

8.4 Vitreoretinal surgery devices 

Chapter 9 Market size and forecast by diagnostic devices 

9.1 Optical coherence tomography (OCT) scanners 

9.2 Fundus cameras 

9.3 Slit lamps 

9.4 Tonometers 

9.5 Ophthalmoscopes 

9.6 Retinoscope 

9.7 Pachymeter 

9.8 Wavefront aberrometers 

9.9 Corneal topographers 

9.10 Biometers 

9.11 Keratometers 

9.12 Visual field analyzers or perimeters 

9.13 Specular microscopes 

9.14 Autorefractors 

9.15 Ophthalmic ultrasound imaging systems 

Chapter 10 Market size and forecast by geography 

10.1 North America 

10.2 Europe 

10.3 Asia 

Chapter 11 Competitive scenario 

11.1 Market share 

11.2 Competitive benchmarking 

Chapter 12 Company profiles 

12.1 Novartis AG 

      12.1.1 Company overview 

      12.1.2 Products and services 

      12.1.3 Financial performance 

      12.1.4 Recent developments 

12.2 Bausch & Lomb Incorporated 

      12.2.1 Company overview 

      12.2.2 Products and services 

      12.2.3 Financial performance

      12.2.4 Recent developments

12.3 Carl Zeiss Meditec AG

      12.3.1 Company overview 

      12.3.2 Products and services

      12.3.3 Financial performance

      12.3.4 Recent developments

12.4 Johnson & Johnson 

      12.4.1 Company overview 

      12.4.2 Products and services 

      12.4.3 Financial performance 

      12.4.4 Recent developments 

12.5 Essilor International 

      12.5.1 Company overview 

      12.5.2 Products and services 

      12.5.3 Financial performance 

      12.5.4 Recent developments 

12.6 HAAG-STREIT GROUP 

      12.6.1 Company overview 

      12.6.2 Products and services 

      12.6.3 Financial performance 

      12.6.4 Recent developments 

12.7 Abbott Laboratories, Inc. 

      12.7.1 Company overview 

      12.7.2 Products and services 

      12.7.3 Financial performance 

      12.7.4 Recent developments 

12.8 NIDEK CO., LTD. 

      12.8.1 Company overview 

      12.8.2 Products and services 

      12.8.3 Financial performance 

      12.8.4 Recent developments 

12.9 TOPCON CORPORATION 

      12.9.1 Company overview 

      12.9.2 Products and services 

      12.9.3 Financial performance 

      12.9.4 Recent developments 

12.10 Ziemer Ophthalmic Systems AG 

      12.10.1 Company overview 

      12.10.2 Products and services 

      12.10.3 Financial performance 

      12.10.4 Recent developments 

12.11 HOYA CORPORATION 

      12.11.1 Company overview 

      12.11.2 Products and services 

      12.11.3 Financial performance 

      12.11.4 Recent developments 


List of Tables

TABLE 1 Market Snapshot: ophthalmic devices market (2014 and 2020) 

TABLE 2 Global data on visual impairment, by region, 2002 and 2010 (million) 

TABLE 3 Globally rising prevalence of diabetics, by number of cases, 2010, 2013, and 2035 (million) 

TABLE 4 Drivers for ophthalmic devices market: impact analysis 

TABLE 5 Out-of-pocket expenditure of developing and developed countries in 2010 

TABLE 6 Restraints for ophthalmic devices market: impact analysis

TABLE 7 Some of the products launched by various companies 

TABLE 8 Global ophthalmic devices market size, by region, 2010 - 2013 (USD million)

TABLE 9 Global ophthalmic devices market size, by region, 2014 - 2020 (USD million) 

TABLE 10 Global ophthalmic devices market size, by type, 2010 - 2013 (USD million) 

TABLE 11 Global ophthalmic devices market size, by type, 2014 - 2020 (USD million) 

TABLE 12 Global ophthalmic devices market size, by vision care devices, 2010 - 2013 (USD million)

TABLE 13 Global ophthalmic devices market size, by vision care devices, 2014 - 2020 (USD million) 

TABLE 14 Global ophthalmic devices market size, by surgery devices, 2010 - 2013 (USD million) 

TABLE 15 Global ophthalmic devices market size, by surgery devices, 2014 - 2020 (USD million) 

TABLE 16 Global ophthalmic devices market size, by diagnostic devices, 2010 - 2013 (USD million) 

TABLE 17 Global ophthalmic devices market size, by diagnostic devices, 2014 - 2020 (USD million) 

TABLE 18 Global vision care devices market size, by region, 2010 - 2013 (USD million) 

TABLE 19 Global vision care devices market size, by region, 2014 - 2020 (USD million) 

TABLE 20 Global ophthalmic surgery devices market size, by region, 2010 - 2013 (USD million) 

TABLE 21 Global ophthalmic surgery devices market size, by region, 2014 - 2020 (USD million) 

TABLE 22 Global ophthalmic diagnostic devices market size, by region, 2010 - 2013 (USD million) 

TABLE 23 Global ophthalmic diagnostic devices market size, by region, 2014 - 2020 (USD million) 

TABLE 24 Global contact lenses market size, by region, 2010 - 2013 (USD million) 

TABLE 25 Global contact lenses market size, by region, 2014 - 2020 (USD million) 

TABLE 26 Global spectacle lenses market size, by region, 2010 - 2013 (USD million) 

TABLE 27 Global spectacle lenses market size, by region, 2014 - 2020 (USD million) 

TABLE 28 Global cataract surgery devices market size, by region, 2010 - 2013 (USD million) 

TABLE 29 Global cataract surgery devices market size, by region, 2014 - 2020 (USD million) 

TABLE 30 Global glaucoma surgery devices market size, by region, 2010 - 2013 (USD million) 

TABLE 31 Global glaucoma surgery devices market size, by region, 2014 - 2020 (USD million) 

TABLE 32 Global refractive error surgery devices market size, by region, 2010 - 2013 (USD million) 

TABLE 33 Global refractive error surgery devices market size, by region, 2014 - 2020 (USD million) 

TABLE 34 Global vitreoretinal surgery devices market size, by region, 2010 - 2013 (USD million) 

TABLE 35 Global vitreoretinal surgery devices market size, by region, 2014 - 2020 (USD million) 

TABLE 36 Global optical coherence tomography scanners market size, by region, 2010 - 2013 (USD million) 

TABLE 37 Global optical coherence tomography scanners market size, by region, 2014 - 2020 (USD million) 

TABLE 38 Global fundus cameras market size, by region, 2010 - 2013 (USD million) 

TABLE 39 Global fundus cameras market size, by region, 2014 - 2020 (USD million) 

TABLE 40 Global slit lamps market size, by region, 2010 - 2013 (USD million) 

TABLE 41 Global slit lamps market size, by region, 2014 - 2020 (USD million) 

TABLE 42 Global tonometer market size, by region, 2010 - 2013 (USD million) 

TABLE 43 Global tonometer market size, by region, 2014 - 2020 (USD million) 

TABLE 44 Global ophthalmoscope in ophthalmic devices market size, by region, 2010 - 2013 (USD million)

TABLE 45 Global ophthalmoscopes market size, by region, 2014 - 2020 (USD million) 

TABLE 46 Global retinoscope market size, by region, 2010 - 2013 (USD million) 

TABLE 47 Global retinoscope market size, by region, 2014 - 2020 (USD million) 

TABLE 48 Global pachymeter market size, by region, 2010 - 2013 (USD million) 

TABLE 49 Global pachymeter market size, by region, 2014 - 2020 (USD million) 

TABLE 50 Global wavefront aberrometers market size, by region, 2010 - 2013 (USD million) 

TABLE 51 Global wavefront aberrometers market size, by region, 2014 - 2020 (USD million) 

TABLE 52 Global corneal topographers market size, by region, 2010 - 2013 (USD million) 

TABLE 53 Global corneal topographers market size, by region, 2014 - 2020 (USD million) 

TABLE 54 Global biometers market size, by region, 2010 - 2013 (USD million) 

TABLE 55 Global biometers market size, by region, 2014 - 2020 (USD million) 

TABLE 56 Global keratometers market size, by region, 2010 - 2013 (USD million) 

TABLE 57 Global keratometers market size, by region, 2014 - 2020 (USD million) 

TABLE 58 Global visual field analyzers market size, by region, 2010 - 2013 (USD million) 

TABLE 59 Global visual field analyzers market size, by region, 2014 - 2020 (USD million) 

TABLE 60 Global specular microscopes market size, by region, 2010 - 2013 (USD million) 

TABLE 61 Global specular microscopes market size, by region, 2014 - 2020 (USD million) 

TABLE 62 Global autorefractors market size, by region, 2010 - 2013 (USD million) 

TABLE 63 Global autorefractors market size, by region, 2014 - 2020 (USD million) 

TABLE 64 Global ophthalmic ultrasound imaging systems market size, by region, 2010 - 2013 (USD million) 

TABLE 65 Global ophthalmic ultrasound imaging systems market size, by region, 2014 - 2020 (USD million) 

TABLE 66 The North American ophthalmic devices market size, by country, 2010 - 2013 (USD million) 

TABLE 67 The North American ophthalmic devices market size, by country, 2014 - 2020 (USD million) 

TABLE 68 The European ophthalmic devices market size, by country, 2010 - 2013 (USD million) 

TABLE 69 The European ophthalmic devices market size, by country, 2014 - 2020 (USD million) 

TABLE 70 The Asian ophthalmic devices market size, by country, 2010 - 2013 (USD million) 

TABLE 71 Global ophthalmic devices market size, by country, 2014 - 2020 (USD million) 

TABLE 72 Major Novartis products and categories 

TABLE 73 Major Bausch & Lomb products and categories 

TABLE 74 Major Carl Zeiss Meditec AG products and categories

TABLE 75 Major Johnson & Johnson products and application 

TABLE 76 Major Essilor International categories and applications 

TABLE 77 Major HAAG-STREIT GROUP products and categories 

TABLE 78 Major Abbott Laboratories products and categories 

TABLE 79 Major NIDEK Co., LTD. products and categories 

TABLE 80 Major TOPCON CORPORATION products and categories 

TABLE 81 Major Ziemer Ophthalmic Systems AG products and categories 

TABLE 82 Major HOYA CORPORATION products and categories


List of Figures 

FIG. 1 Ophthalmic devices market: Porter’s five force analysis 

FIG. 2 Types of ophthalmic devices 

FIG. 3 Aging population in major regions, 2000 - 2050 (%) 

FIG. 4 Global causes of visual impairment in 2010 (%) 

FIG. 5 Global ophthalmic devices market share, by region, by value, 2013

FIG. 6 Global ophthalmic devices market share, by type, by value, 2013 

FIG. 7 Global ophthalmic devices market share, by vision care devices, by value, 2013

FIG. 8 Global ophthalmic devices market share, by surgery devices, by value, 2013 

FIG. 9 Global ophthalmic devices market share, by diagnostic devices, by value, 2013 

FIG. 10 Global vision care devices market share, by region, by value, 2013 

FIG. 11 Global ophthalmic surgery devices market share, by region, by value, 2013

FIG. 12 Global ophthalmic diagnostic devices market share, by region, by value, 2013 

FIG. 13 Global contact lenses market share, by region, by value, 2013 

FIG. 14 Global spectacle lenses market share, by region, by value, 2013

FIG. 15 Global cataract surgery devices market share, by region, by value, 2013

FIG. 16 Global glaucoma surgery devices market share, by region, by value, 2013 

FIG. 17 Global refractive error surgery devices market share, by region, by value, 2013 

FIG. 18 Global vitreoretinal surgery devices market share, by region, by value, 2013 

FIG. 19 Global optical coherence tomography scanners market share, by region, by value, 2013 

FIG. 20 Global fundus cameras market share, by region, by value, 2013 

FIG. 21 Global slit lamps market share, by region, by value, 2013 

FIG. 22 Global tonometer market share, by region, by value, 2013 

FIG. 23 Global ophthalmoscopes market share, by region, by value, 2013 

FIG. 24 Global retinoscope market share, by region, by value, 2013 

FIG. 25 Global pachymeter market share, by region, by value, 2013 

FIG. 26 Global wavefront aberrometers market share, by region, by value, 2013 

FIG. 27 Global corneal topographers market share, by region, by value, 2013 

FIG. 28 Global biometers market share, by region, by value, 2013 

FIG. 29 Global keratometers market share, by region, by value, 2013 

FIG. 30 Global visual field analyzers market share, by region, by value, 2013 

FIG. 31 Global specular microscopes market share, by region, by value, 2013 

FIG. 32 Global autorefractors market share, by region, by value, 2013 

FIG. 33 Global ophthalmic ultrasound imaging systems market share, by region, by value, 2013 

FIG. 34 The North American ophthalmic devices market share, by country, by value, 2013 

FIG. 35 The European ophthalmic devices market share, by country, by value, 2013 

FIG. 36 The Asian ophthalmic devices market share, by country, by value, 2013 

FIG. 37 Market share of ophthalmic devices market in 2013 

FIG. 38 Competitive benchmarking of the ophthalmic devices market 

FIG. 39 Novartis AG net sales and net income, 2011 - 2013 (USD million) 

FIG. 40 Carl Zeiss Meditec AG revenue and net income, 2011 - 2013 (USD million)

FIG. 41 Johnson & Johnson sales and net earnings, 2011 - 2013 (USD million) 

FIG. 42 Essilor International revenue and net profit attributable, 2011 - 2013 (USD million)

FIG. 43 Abbott Laboratories net sales and net earnings, 2011 - 2013 (USD million) 

FIG. 44 TOPCON CORPORATION consolidated net sales and net income, 2010 - 2012 (USD million)

FIG. 45 HOYA CORPORATION sales and net profit, 2011 - 2013 (USD million) 

Back To Top